BioSpace News Archive

Drug Development

Todos Medical Announces Completion of Enrollment for COVID-19 Oral Antiviral 3CLPro (Mpro) Inhibitor Tollovir Phase 2 Clinical Trial Interim Analysis in Severe and Critical Hospitalized Patients

Todos Medical, Ltd. today is very pleased announce an update regarding the ongoing clinical development of Tollovir®, a oral antiviral 3CL protease (3CLpro, Main protease, Mpro, Nsp5) inhibitor & anti-cytokine therapeutic candidate for the treatment of COVID-19.

November 19, 2021
·
8 min read
Business

Invitation to Conference Call Regarding Promore Pharma’s Interim Report for the Third Quarter 2021

Promore Pharma publishes its interim report for the third quarter 2021 on 23 November 2021.

November 19, 2021
·
2 min read
StageZero Life Sciences Introduces BORDERPASS(TM) COVID-19 PCR Testing for Travelers

StageZero Life Sciences, Ltd. today announced the availability of the BORDERPASS™ COVID-19 RT-PCR saliva test.

November 19, 2021
·
4 min read
Biotech Bay

Codexis to Participate in Upcoming Virtual Healthcare Conferences - Nov 19, 2021

Codexis, inc., a leading enzyme engineering company enabling the promise of synthetic biology, announced that management will participate in three upcoming virtual investment conferences.

November 19, 2021
·
1 min read
Genetown

FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics

Datar Cancer Genetics Inc, a leading cancer research company focussed on early detection of cancers today announced that the US Food and Drug Administration (FDA) has granted ‘Breakthrough Device Designation’ for its ‘TriNetra™' blood test to detect early-stage Breast Cancer.

November 19, 2021
·
2 min read
Business

ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directors

ResMed announced it has elected Desney Tan and John Hernandez, both digital health leaders at world-leading tech companies, to its board of directors, during its annual stockholders’ meeting.

November 19, 2021
·
4 min read
Explosive Growth Launches Kraspharma Into REMEDIUM TOP-5

Rafarma Pharmaceuticals, Inc. OTC: reports that PJSC Kraspharma at the end of 2020 entered the TOP-5 of the most dynamic and largest pharmaceutical companies in Russia for 2020, showing incredible growth rates with a net profit increase of 220.9% compared to 2019.

November 19, 2021
·
2 min read
Drug Development

Jaguar Health Announces Topline Results of Investigator-Initiated Phase 2 Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea (CID) in Breast Cancer Patients

Jaguar Health, Inc. announced topline results of the third-party, investigator-initiated Phase 2 HALT-D trial evaluating crofelemer for the prevention of chemotherapy-induced diarrhea in HER2-positive breast cancer patients being treated with trastuzumab, pertuzumab and a taxane.

November 19, 2021
·
10 min read
Business

Arvinas and Pfizer Announce Updated Phase 1 Dose Escalation Data for ARV-471 to be Presented in Spotlight Poster Session at 2021 San Antonio Breast Cancer Symposium

Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) announced today that updated safety and efficacy data from the Phase 1 dose escalation trial of ARV-471 will be presented in a spotlight poster-discussion session at the 2021 San Antonio Breast Cancer Symposium (SABCS) on December 7-10, 2021.

November 19, 2021
·
9 min read
Biovica’s DiviTum(R)TKa in Three Studies at SABCS 2021

Biovica, active in cancer diagnostics, announced that results from three different studies using DiviTum®TKa, including a budget impact model, will be presented at the world’s largest breast cancer symposium, San Antonio Breast Cancer Symposium, in early December.

November 19, 2021
·
3 min read